SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffrey Beckman who wrote (745)3/16/1998 7:11:00 PM
From: glenn l holzer  Read Replies (1) of 1055
 
To all;

Found my IBD in my briefcase - INIS has a multi million $ contract and $1mil cash infusion for development sharing with Imagyn Medical Technologies and to supply IMT with product. INIS wont get any product money until FDA approval.

Analyts expect radioisotopes to be $10 Bil industry by 2020, currently
$1.3 Bil - or roughly 5+ X's from here.

INIS bought from Uncle a linear accelerator, which cost us taxpayers $50 mil, for $2.9 Mil. LINAC'S can do 2-3x as many seeds as cyclotrons such as used by THRX. They are very powerful.

Very condensed, but hope that helps.

I think there is room for all - only four major seed makers incl.
THRX & INIS will be fifth, when they get on line.

I am in for LT on THRX & may dip into INIS after seeing what shakes out.

Good luck to all.

Regards, Glenn
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext